Envoy Medical CEO and Patient Discuss Fully Implanted Hearing Breakthrough

Aug 7, 2026

Envoy Medical (NASDAQ: COCH) CEO Brent Lucas and patient Peter Kirk discuss the life-changing potential of the company’s investigational Acclaim® Fully Implanted Cochlear Implant. After years of progressive hearing loss and unsuccessful experiences with traditional hearing aids, Kirk shares how receiving one of the first Acclaim implants restored his ability to hear conversations, everyday sounds, and reconnect with family, work, and daily life.

Lucas explains how Envoy Medical’s fully implanted technology differs from conventional cochlear implants by using the ear’s natural anatomy instead of an external microphone, enabling continuous 24/7 hearing without external hardware. He also discusses the company’s ongoing pivotal FDA clinical trial, the path toward commercial approval, and why fully implanted hearing technology could transform treatment for millions of people living with severe to profound hearing loss.

#EnvoyMedical
#COCH
#CochlearImplant
#HearingLoss
#HearingHealth
#MedicalDevices
#ClinicalTrials
#Biotechnology
#HealthcareInnovation
#FDA
#LifeSciences
#MedicalTechnology
#NASDAQ
#JaneKing
#NewsOut